Please login to the form below

Not currently logged in
Email:
Password:

Takeda appoints head of vaccines development

John Boslego will succeed Ralf Clemens

edit-Boslego-photo-2Takeda Pharmaceuticals has appointed John Boslego as senior vice president and head of development for its global vaccine business unit, effective from December 1.

He succeeds Ralf Clemens, who has served in the role since the launch of Takeda's vaccine business division in January 2012.

Boslego will be responsible for accelerating global vaccine development activities with a focus on lead development programmes for dengue, norovirus and seasonal influenza. He will report to Rajeev Venkayya, president of Takeda's global vaccine business unit.

Commenting on the appointment, Venkayya said: “John brings a wealth of vaccine development and global health experience to Takeda at an important time.

“He takes the helm of an outstanding development team that was built by Ralf Clemens and I have the utmost confidence in their ability to deliver our exciting pipeline.”

Boslego has work in vaccine clinical research and development for over 40 years and was most recently director of the vaccine development global programme at PATH, where he built a vaccine development organisation and advanced vaccine development against illnesses including rotavirus, polio and meningococcus.

He has also served as executive director of biologics, clinical research at Merck & Co and prior to this, directed the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand.

14th October 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics